Oryx International Growth Fund Ld Interim Management Statement (7981M)
August 29 2013 - 11:49AM
UK Regulatory
TIDMOIG
RNS Number : 7981M
Oryx International Growth Fund Ld
29 August 2013
ORYX INTERNATIONAL GROWTH FUND LIMITED
INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 30 JUNE
2013
Oryx International Growth Fund Limited ("Oryx" or the
"Company"), is publishing this Interim Management Statement in
accordance with DTR 4.3 of the FCA Handbook.
This interim management statement has been produced solely to
provide additional information to shareholders as a body to meet
the relevant requirements of the UK Listing Authority's Disclosure
and Transparency Rules. It should not be relied upon by any other
party or for any other purpose.
This interim management statement relates to the period from 1
April 2013 to 30 June 2013, and contains information that covers
this period, and up to the date of publication of this interim
management statement, unless otherwise specified.
Manager's Review
During the period under review, the FTSE Small Cap Index
returned 2.6% and the FTSE All-Share Index returned -3.3%. Against
this, the Company's net asset value rose by 1.9% to 385p per share.
The Company has benefited from the recent improvement in market
conditions and we are pleased to report that the net asset value
per share has reached an all-time high.
As reported previously, a number of the companies in the
Unquoted portfolio are in the process of corporate activity. Since
the end of the period under review, Bionostics has, in fact, been
sold and the sale proceeds have been received.
Material Transactions
During the quarter ended 30 June 2013, the Company purchased
78,488 numbers of shares for the purposes of cancellation.
Material Events
There were no material events during the quarter ended 30 June
2013.
Report and Accounts
On 18 July 2013, the Company released its Annual Report and
Condensed Consolidated Financial Statements for the year ended 31
March 2013, to Shareholders.
Financial Highlights
30 June 31 March 31 December 30 September 30 June 2012
2013 2013 2012 2012
NAV GBP3.85 GBP3.78 GBP3.48 GBP3.22 GBP2.93
US Dollar / Sterling
Exchange Rate 1.516744 1.518218 1.6254 1.6148 1.5685
Twenty Largest Equity Investments at 30 June 2013
DETAILS % NET ASSETS
----------------------------------- -------------
NASTOR INV LTD ZERO REDEEM PREFER
SHARES 1.00
MECOM GROUP PLC 2.00
SINAV LIMTED 2.00
TEAM ROCK PREFERENCE GBP SHARES 2.00
AUGEAN PLC 3.00
ECKOH PLC 3.00
BIONOSTICS HOLDINGS LTD 4.00
CELSIS AG 4.00
GUINNESS PEAT GROUP PLC 5.00
IFG GROUP PLC 5.00
JOURNEY GROUP PLC 5.00
ORTHOPRODUCTS LTD 5.00
CATALYST MEDIA GROUP PLC 5.00
CVS GROUP PLC 5.00
CYPROTEX PLC 5.00
ASSETCO PLC 5.00
BIOQUELL PLC 6.00
QUARTO GROUP INC 6.00
GOALS SOCCER CENTRES PLC 7.00
GLEESON (M.J.) GROUP PLC 14.00
TOTAL 94.00
----------------------------------- -------------
The financial information for the quarter ended 30 June 2013
contained within this Interim Management Statement has not been
audited.
By order of the Board
BNP Paribas Securities Services S.C.A., Guernsey Branch , for
and on behalf of
Oryx International Growth Fund Limited
as Company Secretary
This information is provided by RNS
The company news service from the London Stock Exchange
END
IMSPGUMCRUPWGAB
Oryx International Growth (LSE:OIG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Oryx International Growth (LSE:OIG)
Historical Stock Chart
From Jul 2023 to Jul 2024